Gain Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4800 Hampden Lane, Suite 200, Bethesda, MD

There are no Buy or Sell transactions made by insiders since 10/24/2024

Gain Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthias Alder Chief Executive Officer, Director $2.28M Mar 26, 2024
Eric I. Richman Director $1.26M Jun 24, 2025
Gene Mack CEO, President, Director $1.19M Mar 20, 2025
Khalid Islam Director $1.02M Jun 24, 2025
Charles Evan Ballantyne Chief Financial Officer $711K Apr 10, 2023
Salvatore Calabrese Chief Financial Officer $363K Mar 23, 2023
Gianluca Fuggetta Principal Accounting and Financial Officer $293K Mar 20, 2025
Claude Nicaise Director $87.9K Jun 24, 2025
Dov A. Md Goldstein Director $87.9K Jun 24, 2025
Gwen A. Melincoff Director $87.9K Jun 24, 2025
Hasler Hans Peter Director $87.9K Jun 24, 2025
Jeffrey Scott Riley Director $87.9K Jun 24, 2025

Recent Insider Transactions by Companies or Individuals for Gain Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.